Agree - seems that an OL spin off with a partner to finance the new trial would work best. As with NGIO, GNBT can maintain a healthy share. And us shareholders can get dividends from another spinoff. Sounds like a plan!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
